BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 9:28:00 AM | Browse: 1196 | Download: 1103
 |
Received |
|
2013-12-29 16:21 |
 |
Peer-Review Started |
|
2013-12-29 19:56 |
 |
To Make the First Decision |
|
2014-02-13 16:21 |
 |
Return for Revision |
|
2014-02-20 23:45 |
 |
Revised |
|
2014-03-04 08:11 |
 |
Second Decision |
|
2014-05-14 16:28 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-14 16:41 |
 |
Articles in Press |
|
2014-05-23 12:30 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-07-01 09:05 |
 |
Publish the Manuscript Online |
|
2014-07-19 23:48 |
Category |
Orthopedics |
Manuscript Type |
Topic Highlights |
Article Title |
New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty
|
Manuscript Source |
Invited Manuscript |
All Author List |
Garrett B Aikens, Jacob R Osmundson and Michael P Rivey |
Funding Agency and Grant Number |
|
Corresponding Author |
Garrett B Aikens, PhD, BCACP, Department of Pharmacy, Central Alabama Veterans Health Care System, Montgomery, Columbus CBOC, 1310 13th Avenue, Columbus, AL 36109, United States. garrett.aikens@va.gov |
Key Words |
Oral; Thromboprophylaxis; Venous thromboembolism; Hip; Arthroplasty |
Core Tip |
This review focuses on the drug-specific characteristics, efficacy, safety, and economic impact of the target specific oral anticoagulants including dabigatran, rivaroxaban, apixaban, and edoxaban for thromboprophylaxis following total hip arthroplasty, as well as the aspects of therapeutic monitoring and anticoagulation reversal in the event of bleeding complications or a need for urgent reversal. |
Publish Date |
2014-07-19 23:48 |
Citation |
Aikens GB, Osmundson JR, Rivey MP. New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty. World J Orthop 2014; 5(3): 188-203 |
URL |
http://www.wjgnet.com/2218-5836/full/v5/i3/188.htm |
DOI |
http://dx.doi.org/10.5312/wjo.v5.i3.188 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345